Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark

Diabetes Care
Signe T AndersenMorten Charles

Abstract

To study incident diabetic polyneuropathy (DPN) prospectively during the first 13 years after a screening-based diagnosis of type 2 diabetes and determine the associated risk factors for the development of DPN. We assessed DPN longitudinally in the Danish arm of the Anglo-Danish-Dutch study of Intensive Treatment of Diabetes in Primary Care (ADDITION) using the Michigan Neuropathy Screening Instrument questionnaire (MNSIQ), defining DPN with scores ≥4. Risk factors present at the diabetes diagnosis associated with the risk of incident DPN were estimated using Cox proportional hazard models adjusted for trial randomization group, sex, and age. Of the total cohort of 1,533 people, 1,445 completed the MNSIQ at baseline and 189 (13.1%) had DPN at baseline. The remaining 1,256 without DPN entered this study (median age 60.8 years [interquartile range 55.6; 65.6], 59% of whom were men). The cumulative incidence of DPN was 10% during 13 years of diabetes. Age (hazard ratio [HR] 1.03 [95% CI 1.00; 1.07]) (unit = 1 year), weight (HR 1.09 [95% CI 1.03; 1.16]) (unit = 5 kg), waist circumference (HR 1.14 [95% CI 1.05; 1.24]) (unit = 5 cm), BMI (HR 1.14 [95% CI 1.06; 1.23]) (unit = 2 kg/m2), log2 methylglyoxal (HR 1.45 [95% CI 1.12; 1.89]) ...Continue Reading

References

Nov 4, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·T LauritzenUNKNOWN Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care
Jan 28, 2005·The New England Journal of Medicine·Solomon TesfayeUNKNOWN EURODIAB Prospective Complications Study Group
May 28, 2010·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Susan van DierenBruce Neal
Sep 30, 2010·Diabetes Care·Solomon TesfayeUNKNOWN Toronto Diabetic Neuropathy Expert Group
Feb 1, 2012·Diabetes/metabolism Research and Reviews·Solomon Tesfaye, Dinesh Selvarajah
May 23, 2012·Lancet Neurology·Brian C CallaghanEva L Feldman
Jun 15, 2012·The Cochrane Database of Systematic Reviews·Brian C CallaghanRichard A C Hughes
Aug 7, 2012·The Journal of Toxicological Sciences·Susumu OhkawaraHideto Jinno
Aug 16, 2012·Current Opinion in Neurology·Brian C CallaghanEva L Feldman
Aug 21, 2014·Current Diabetes Reports·Lynn AngRodica Pop-Busui
Nov 21, 2014·Handbook of Clinical Neurology·Dan ZieglerJonathan E Shaw
Mar 13, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·C S HansenM E Jørgensen
Mar 17, 2015·Diabetology & Metabolic Syndrome·Ling HanBin Lu
Dec 18, 2015·The Review of Diabetic Studies : RDS·Nikolaos Papanas, Dan Ziegler
Sep 23, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Rens HanewinckelPieter A van Doorn
Dec 22, 2016·Diabetes Care·Rodica Pop-BusuiDan Ziegler
Jan 19, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Anna GrisoldEva L Feldman
Jan 22, 2017·Neuroscience and Biobehavioral Reviews·Omer Van den BerghRichard J Brown
May 6, 2017·International Journal of Molecular Sciences·Sebastian BringsPeter P Nawroth

❮ Previous
Next ❯

Citations

Jul 11, 2018·Diabetes Care·Signe T AndersenMorten Charles
Sep 27, 2018·Endocrine Reviews·Gidon J BönhofDan Ziegler
Sep 11, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S S GylfadottirN B Finnerup
May 9, 2019·Current Diabetes Reports·Pallai ShilloSolomon Tesfaye
Feb 20, 2020·Current Opinion in Endocrinology, Diabetes, and Obesity·Masha G SavelieffEva L Feldman
Feb 10, 2020·Journal of Neural Transmission·Daniela C RosenbergerRolf-Detlef Treede
Jul 13, 2019·Current Pharmaceutical Design·Niki KatsikiDimitri P Mikhailidis
Jun 17, 2020·Diabetologia·Jeroen H P M van der VeldeNicolaas C Schaper
Nov 6, 2018·Pharmaceuticals·Ari KoivistoAntti Pertovaara
Jan 25, 2020·Diabetologia·Brian C CallaghanEva L Feldman
Jun 15, 2019·Nature Reviews. Disease Primers·Eva L FeldmanVijay Viswanathan
Nov 4, 2020·Deutsche medizinische Wochenschrift·Svenja Meyhöfer, Sebastian M Schmid
Oct 2, 2020·Diabetes Care·Frederik P KristensenReimar W Thomsen
Nov 19, 2020·Pediatric Diabetes·Gulcin AkinciEva L Feldman
Nov 10, 2020·Molecular Metabolism·Alexander StromUNKNOWN GDS Group
Nov 24, 2019·Trends in Endocrinology and Metabolism : TEM·Rasmus Kold-Christensen, Mogens Johannsen
Jan 6, 2021·Cardiovascular Diabetology·Kamel MohammediMark Woodward
Oct 30, 2020·International Journal of General Medicine·Fahad A S AleidanAbdel Galil Abdel Gader
Mar 7, 2021·International Journal of Molecular Sciences·Yoshikai FujitaAkihiro Nakamura
Mar 7, 2021·Biomolecules·Mohammad Sarif MohiuddinHideki Kamiya
Jul 6, 2020·Mayo Clinic Proceedings·Brian C CallaghanEva L Feldman
Apr 3, 2019·Trends in Endocrinology and Metabolism : TEM·Christian HerderDan Ziegler
Apr 15, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Kalie L TommerdahlPetter Bjornstad

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.